Abstract
Over the past twenty-five years, hepatic resection has evolved from a high risk, resource intensive procedure with limited application to a safe and commonly performed operation, with broad indications. This period has seen dramatic improvement in perioperative outcome, including reductions in mortality, blood loss, transfusion rates, and hospital stay [1]–[2]. These improved perioperative results are largely responsible for the emergence of hepatic resection as a viable and effective treatment option for selected patients with 1 and 2 hepatobiliary malignancy. Continued advances in imaging technology, along with a heightened awareness of the clinical and tumour-related variables that dictate outcome, have allowed better preoperative assessment of disease extent and improved patient selection. Advances in other areas, such as minimally invasive and ablative techniques, have increased the treatment options and have had some impact on the approach to patients with malignant hepatobiliary disease. However, resection remains the most effective therapy
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Dematteo R.P., Fong Y., Jarnagin E., Blumgart L.H., Recent advances in hepatic resection, 2000, Sem Surg Onc, vol. 19, p. 200–207.
Takayama T., Makuuchi M., Kubota K., et al., Randomised comparison of ultrasonic vs clamp transection of the liver, 2001, Arch. Surg, vol. 136, p. 922–928.
Jarnagin WR, Gonen M, Fong Y et al. Improvement in perioperative outcome after hepatic resection. Analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236:397–407.
Kooby DA, Stockman J, Ben-Porat L. Influence of transfusion on perioperative and long term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237:860–869.
Marin-Hargreaves G., Azoulay D., Bismuth H., Hepatocellular Carcinoma: surgical indications and results, 2003, Critical Rev in Oncol, vol. 47, p. 13–27.
Sarmiento J.M., Que F.G., Hepatic surgery for metastases from neuroendocrine tumours, 2003, Surg Clin N Am, vol. 12, p. 231–242.
Kooby D.A., Jarnagin W.R., Surgical management of hepatic malignancy, 2004, Cancer Invest, vol. 22, p. 283–303.
Simmonds P.C., Primrose J.N., Colquitt J.L. et al., Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies, 2006, Br J of Cancer, vol. 94, p. 982–999.
Teo M.C., Tan Y M., Chung A.Y., et al, Metastatectomy for non-colorectal, non-neuroendocrine liver secondaries, 2006, ANZ J. Surg, vol. 76, p. 575–578.
Lesurtel M., Selzner M., Petrowsky H., et al., How should transection of the liver be performed ?, 2005, Ann Surg, vol. 242, p. 814–823.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag/Wien
About this chapter
Cite this chapter
Healy, A., Tracey, J., Habib, N.A., Jiao, L.R. (2006). Indications for Liver Resection. In: Karaliotas, C.C., Broelsch, C.E., Habib, N.A. (eds) Liver and Biliary Tract Surgery. Springer, Vienna. https://doi.org/10.1007/978-3-211-49277-2_28
Download citation
DOI: https://doi.org/10.1007/978-3-211-49277-2_28
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-49275-8
Online ISBN: 978-3-211-49277-2
eBook Packages: MedicineMedicine (R0)